An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

Nov 3 (Reuters) - Moderna Inc (MRNA.O), opens new tab on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023 outlook for the shots well ...

In the United States, approximately 658 million Covid-19 vaccine doses have been administered since they were first distributed exactly two years ago Wednesday. Framing the significance of preventive ...

It’s fall, which means it’s time to get updated on the winter season shots. That includes vaccines for flu, RSV (for babies and the elderly) and, for anyone six months or older, COVID-19. While the ...

Professor Ana Santos Rutschman, recently of SLU LAW and currently Professor of Law at Villanova University Charles Widger School of Law, returned to SLU as a Distinguished Speaker to discuss her new ...

Every time Catherine publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (BWV), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today ...

Comments by President Trump, Health Secretary Robert F. Kennedy Jr. and some panelists suggest the committee is likely to ...